226 related articles for article (PubMed ID: 31557322)
1. Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice.
Lemos H; Mohamed E; Huang L; Chandler PR; Ou R; Pacholczyk R; Mellor AL
Immunology; 2019 Dec; 158(4):353-361. PubMed ID: 31557322
[TBL] [Abstract][Full Text] [Related]
2. Activation of the STING adaptor attenuates experimental autoimmune encephalitis.
Lemos H; Huang L; Chandler PR; Mohamed E; Souza GR; Li L; Pacholczyk G; Barber GN; Hayakawa Y; Munn DH; Mellor AL
J Immunol; 2014 Jun; 192(12):5571-8. PubMed ID: 24799564
[TBL] [Abstract][Full Text] [Related]
3. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
Lemos H; Mohamed E; Ou R; McCardle C; Zheng X; McGuire K; Homer NZM; Mole DJ; Huang L; Mellor AL
Front Immunol; 2020; 11():1256. PubMed ID: 32625215
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses.
Huang L; Li L; Lemos H; Chandler PR; Pacholczyk G; Baban B; Barber GN; Hayakawa Y; McGaha TL; Ravishankar B; Munn DH; Mellor AL
J Immunol; 2013 Oct; 191(7):3509-13. PubMed ID: 23986532
[TBL] [Abstract][Full Text] [Related]
5. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
7. Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.
Huang L; Lemos HP; Li L; Li M; Chandler PR; Baban B; McGaha TL; Ravishankar B; Lee JR; Munn DH; Mellor AL
J Immunol; 2012 May; 188(10):4913-20. PubMed ID: 22516958
[TBL] [Abstract][Full Text] [Related]
8. Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes.
Androulidaki A; Wachsmuth L; Polykratis A; Pasparakis M
PLoS One; 2018; 13(3):e0194048. PubMed ID: 29522531
[TBL] [Abstract][Full Text] [Related]
9. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
[TBL] [Abstract][Full Text] [Related]
10. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
[TBL] [Abstract][Full Text] [Related]
11. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
[TBL] [Abstract][Full Text] [Related]
12. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
13. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
[TBL] [Abstract][Full Text] [Related]
14. STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer.
Shi J; Liu C; Luo S; Cao T; Lin B; Zhou M; Zhang X; Wang S; Zheng T; Li X
Cell Immunol; 2021 Aug; 366():104384. PubMed ID: 34182334
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice.
Tan Q; Tai N; Li Y; Pearson J; Pennetti S; Zhou Z; Wong FS; Wen L
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321370
[TBL] [Abstract][Full Text] [Related]
16. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
Orabona C; Mondanelli G; Pallotta MT; Carvalho A; Albini E; Fallarino F; Vacca C; Volpi C; Belladonna ML; Berioli MG; Ceccarini G; Esposito SM; Scattoni R; Verrotti A; Ferretti A; De Giorgi G; Toni S; Cappa M; Matteoli MC; Bianchi R; Matino D; Iacono A; Puccetti M; Cunha C; Bicciato S; Antognelli C; Talesa VN; Chatenoud L; Fuchs D; Pilotte L; Van den Eynde B; Lemos MC; Romani L; Puccetti P; Grohmann U
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563329
[TBL] [Abstract][Full Text] [Related]
18. STING-associated lung disease in mice relies on T cells but not type I interferon.
Luksch H; Stinson WA; Platt DJ; Qian W; Kalugotla G; Miner CA; Bennion BG; Gerbaulet A; Rösen-Wolff A; Miner JJ
J Allergy Clin Immunol; 2019 Jul; 144(1):254-266.e8. PubMed ID: 30772497
[TBL] [Abstract][Full Text] [Related]
19. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
20. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
